Henrik Birk has been appointed chief operating officer at Bavarian Nordic A/S which is developing cancer immunotherapies and vaccines for infectious disease. He joined the Danish company in 2008 and most recently was senior vice president for strategy, people and organisation. In his new position he will report to the chief executive Paul Chaplin. Mr Birk holds a Master of Business Administration from the Henley Business School in the UK.
Bavarian Nordic announced the appointment on 17 January 2017.
Copyright 2017 Evernow Publishing Ltd